Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic medtronic Consolidated — Emerging Markets Organic Growth (Legacy through FY2024Q4, %) (%)
Medtronic Form 8-K Geographic Revenue Tables (FY2016–FY2024)
Latest, Q4 FY24
13.1%
Period ended Apr 30, 2024
Change on a year earlier
+2.5 pts
10.6% in Q4 FY23
History
31 quarters
Since Q3 FY16
Sources
31
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Medtronic Medtronic Consolidated — Emerging Markets Organic Growth (Legacy through FY2024Q4, %) (%), quarterly Q3 FY16–Q4 FY24 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/tot-mdt-em-leg-org
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.